Berson A, Nativio R, Berger SL, Bonini NM
10.1128/mmbr.00015-13 28 FordA
The increasing prevalence of obesity worldwide and its associated pressure on healthcare systems, along with the reputation of GLP-1 drugs for inducing significant weight loss (approximately 1525+%, significantly higher than previous generations of obesity drugs), are driving GLP-1 drug expansion into new markets like China
Peptide Characterisation and Research Quality Parameters Research-grade GHK-Cu is characterised by HPLC purity 98% (C18 RP
Studies are organized by publication year, brain region, disease, age, experimental conditions, species, omics techniques, characteristic molecules, key observations, and references